IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sabby Management, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 124 holdings | $13.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cel-Sci Corp(CVM1EUR)COM150837607$10124,8160.0%
Aytu Bioscience Inc(AYTUUSD)COM054754700$9835,4660.0%
Sellas Life Sciences Group IncCOM81642T100$9678,2940.0%
Sigma Labs Inc*W826598112$87280,5290.0%
Durect CorpCallCOM266605904$696270.0%
Yield10 Bioscience IncCOM98585K201$6847,7400.0%
RXI Pharmaceuticals*W74979C121$68195,2590.0%
Onconova Therapeutics Inc*W68232V116$67665,4700.0%
Stellar Biotechnologies IncCOM85855A302$6546,8590.0%
Scynexis IncCOM811292101$5041,5790.0%
Kitov Pharma LTDADR49803V107$4727,0430.0%
Pluristem Therapeutics IncPutCOM72940R952$413120.0%
Electrameccanica Vehicles Corp*W284849114$38101,0000.0%
Opgen Inc COM NewCOM68373L208$3416,9580.0%
Ophthotech CorpPutCOM683745953$311330.0%
Cormedix IncPutCOM21900C950$282870.0%
Citius Pharmaceuticals IncCOM17322U207$2011,5640.0%
Reshape Lifesciences IncCOM761123405$20461,7040.0%
Benitec Biopharma LTD*W082053117$758,0500.0%
Inspiremd Inc*W45779A135$71,847,6360.0%
Cesca Therapeutics IncCOM157131202$619,9880.0%
Inspiremd Inc*W45779A127$1498,7970.0%
Helios and Matheson Analytics IncCallCOM42327L909$01250.0%
Cytori Therapeutics*W23283K121$037,7930.0%
PreviousPage 3 of 3